Skip to content

The Christchurch Heart Failure Registry

Neurohormonal activation in people admitted to hospital with heart failure: it's role as a marker of severity of heart failure, cardiac function, response to treatment and prognosis.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12606000216516
Acronym
nil known
Enrollment
2500
Registered
2006-05-31
Start date
1997-12-01
Completion date
2002-12-31
Last updated
2024-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study will collect data from all patients admitted to Christchurch Hospital with heart failure over 2.5 years. Information will be collected from each patient about his/her background medical condition, results of routine tests performed during their hospital admission including blood tests, chest x-ray and cardiac scans. In addition 2 extra blood tests will be performed to look at levels of hormones produced by the heart and other parts of the body in response to heart failure. The first test will be performed within 24 hours of hospital admission, and the second just prior to discharge. We will follow the progress of each participant after discharge to keep a record of sunsequent readmissions or death during the 5 year period following discharge. We will analyse the hormone tests and other information collected to determine whether these results enable us to predict the severity of heart failure, the response to treatment and the overall outcome/outlook fo people admitted to hospital with heart failure.

Interventions

neurohormonal levels and their relationship to severity of heart failure, cardiac function, response to treatment and overall prognosis for 5 years following discharge from hospital for heart failure

Sponsors

Health Research Council of New Zealand
Lead SponsorGovernment body

Eligibility

Sex/Gender
All
Healthy volunteers
No

Inclusion criteria

All patients with heart failure as a primary or secondary diagnosis.

Exclusion criteria

Any patient unable to give informed consent.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026